Literature DB >> 188445

Isolation and characterization of DNA-DNA and DNA-RNA.

S Salzberg, Z Levi, M Aboud, A Goldberger.   

Abstract

A simple method for the isolation and characterization of DNA-DNA and DNA-RNA hybrid molecules formed in solution was developed. It was based on the fact that, in appropriate salt concentration, such as 5% Na2HPO4, DNA in either double-stranded (DNA-DNA or DNA-RNA) or single-stranded forms, but not free nucleotides, can bind to diethylaminoethylcellulose disc filters (DE81). Thus tested samples were treated with the single-strand-specific nuclease S1 and then applied to DE81 filters. The free nucleotides, resulting from degrading the single-stranded molecules, were removed by intensive washing with 5% Na2HPO4, leaving only the hybrid molecules on the filters. The usefulness of this method was illustrated in dissociation and reassociation studies of viral (SV40) or cellular (NIH/3T3) DNAs and DNA-RNA hybrid molecules. Using this technique the reassociation of denatured SV40 DNA was found to be a very rapid process. Dissociation studies revealed that the melting curves of tested DNAs were dependent on salt concentration. Thus the melting temperatures (tm) obtained for SV40 DNA were 76 degrees C at 1 X SSC (0.15 M NaCl-0.015 M sodium citrate) and 65 degrees C at 0.1 X SSC, and for NIH/3T3 DNA 82 degrees C at 1 X SSC and 68 degrees C at 0.1 X SSC. MuLV DNA-RNA hybrid molecules were formed by annealing in vitro synthesized MuLV DNA with 70S MuLV RNA at 68 degrees C. The melting temperature of this hybrid in the annealing solution was 87 degrees C. Another important feature of this procedure was that, after being selectively bound to the filters, the hybrid molecules could efficiently be recovered by heating the filters for 5 min at 60 degrees C in 1.5-1.7 M KCl. The recovered molecules were intact hybrids as they were found to be completely resistant to S1 nuclease.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 188445     DOI: 10.1021/bi00620a004

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Viral genome RNA serves as messenger early in the infectious cycle of murine leukemia virus.

Authors:  R Shurtz; S Dolev; M Aboud; S Salzberg
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

2.  Accelerated loss of telomeric repeats may not explain accelerated replicative decline of Werner syndrome cells.

Authors:  V P Schulz; V A Zakian; C E Ogburn; J McKay; A A Jarzebowicz; S D Edland; G M Martin
Journal:  Hum Genet       Date:  1996-06       Impact factor: 4.132

3.  Characterization of intracellular viral RNA in interferon-treated cells chronically infected with murine leukemia virus.

Authors:  S Salzberg; M Bakhanashvili; S Bari; I Berman; M Aboud
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

4.  Cytoplasmic viral DNA synthesis in exogenous infection of murine leukemia virus: effect of interferon and cycloheximide.

Authors:  M Aboud; D Moldovan-Levin; S Salzberg
Journal:  J Virol       Date:  1981-02       Impact factor: 5.103

5.  Intracellular production of virus particles and viral components in NIH/3T3 cells chronically infected with Moloney murine leukemia virus: effect of interferon.

Authors:  M Aboud; R Kimchi; M Bakhanashvili; S Salzberg
Journal:  J Virol       Date:  1981-12       Impact factor: 5.103

6.  Methods for assessing DNA hybridization of peptide nucleic acid-titanium dioxide nanoconjugates.

Authors:  Eric M B Brown; Tatjana Paunesku; AiGuo Wu; K Ted Thurn; Benjamin Haley; Jimmy Clark; Taisa Priester; Gayle E Woloschak
Journal:  Anal Biochem       Date:  2008-08-26       Impact factor: 3.365

7.  Effect of interferon on the penetration of murine leukemia virus and the binding of its genome RNA to polyribosomes at the early stage of infection.

Authors:  S Salzberg; R Shurtz; J Feder; M Aboud
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

8.  Inhibition of retrovirus DNA supercoiling in interferon-treated cells.

Authors:  M Huleihel; M Aboud
Journal:  J Virol       Date:  1983-10       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.